Mung Bean Extract for Health & Longevity - Quick Reference Sheet

Mung Bean Extract for Health & Longevity

Created on 10/08/2026 – Quick Reference based on Evidence Review created using AI4L + evidence-mcp / Sonnet 5.5 – Audit

Mung bean extract is a concentrated preparation of the green gram legume, mainly a seed-coat extract sold as a supplement, studied for health and longevity. Support comes mostly from laboratory and animal work. The few small human trials tested the bean's protein, not the seed-coat extract, so no benefit reaches more than low confidence. Documented risks are allergic reactions and bacterial contamination of raw sprouts. (Full Review)

Protocol

Seed-coat extract (supplement label)
240 mg extract, one capsule daily
Provides 24 mg vitexin and 24 mg isovitexin, with 300 mg EGCG (green tea compound), without food; no human trial supports this dose
Protein isolate (metabolic trials)
3 g/day for 8 weeks
Chewable tablets twice daily before breakfast and dinner; 6 g/day tested for 4 weeks
Protein supplement (strength trial)
18 g/day for 8 weeks
Mung bean protein taken in the morning
Time to effect
Metabolic changes (protein isolate)
4-8 weeks
Seen at 4 weeks in the pre-study and 8 weeks in the main study
Artery-function changes
6 weeks
Seen in the artery-function trial
Beyond 8 weeks
No data exist
Trials lasted 4-8 weeks

Benefits

Contraindications
  • Individuals with mung bean, soy, peanut or lupin allergy
  • Individuals with birch-pollen allergy and prior reactions to mung bean sprouts or soy foods
  • Pregnant and breastfeeding individuals (theoretical)
Key Interactions
  • Glucose-lowering drugs (metformin, glipizide, insulin): Monitor (theoretical)
  • Blood-pressure drugs (ACE inhibitors such as lisinopril and enalapril): Monitor (theoretical)
  • Thyroid medication (levothyroxine, methimazole): Monitor (theoretical)
  • NSAIDs (ibuprofen, naproxen): Low concern (theoretical)
  • Green tea extract (EGCG): Monitor (theoretical)
  • Iron and zinc supplements: Caution (theoretical)
  • Supplements with overlapping glucose- or blood-pressure-lowering effects (berberine, cinnamon, hibiscus): Monitor (theoretical)
  • Low-glycemic diets and exercise programs: Monitor (theoretical)

Risk & Side Effects

  • High:
  • Medium:
  • Low: Allergic Reactions; Foodborne Infection From Raw Sprouts
  • Speculative: Thyroid Hormone Synthesis Interference; Trace-Element Exposure; Anti-Nutritional Factors

Monitoring

Marker Target Why
Fasting glucose About 70-99 mg/dL (standard reference range; varies by laboratory) Safety check: additive lowering with glucose-lowering drugs could cause hypoglycemia
Fasting insulin About 2-25 µU/mL (standard reference range; varies by laboratory) Expected-change marker: fell in the isolate trial
HOMA-IR No established target; track change from own baseline Expected-change marker of insulin resistance
Triglycerides No established target; track change from own baseline Expected-change marker: shifted in the isolate trial
ALT About 7-56 U/L (standard reference range; varies by laboratory) Expected-change marker: fell in the isolate trial
Blood pressure No established target; track change from own baseline Safety check: theoretical additive lowering with blood-pressure drugs

Cadence: Baseline before starting; at 4 weeks, 8 weeks, then every 3-6 months while use continues (common practice; trials ended at 4-8 weeks)

Qualitative Assessment

  • Energy levels and exertional tolerance
  • Grip or leg strength
  • Digestive comfort (bloating, flatulence)
  • Pruritus (itching), oral tingling or urticaria (hives) after dosing